An FDA committee will discuss Moderna boosters. Here’s what to expect

This week marks another potential watershed moment for Moderna Inc.’s Covid-19 vaccine: A key advisory committee to the U.S. Food and Drug Administration is set to meet to discuss so-called "booster shots."
Click here to view original post